Infectious diseases present an ever changing panorama. While change and advance are not synonymous, changes in human behaviour-by presenting urgent new dilemmas-may lead to advances in understanding of disease and its transmission. The first decade of awareness of the illness now known to be due to the human immunodeficiency virus (HIV) will have been remarkable in this respect. Some of the advances in childhood infectious illness that have also occurred in the last 10 years or so together with some future priorities, inevitably personal ones, will be reviewed here.
Some recent advances 'NEW' INFECTIOUS ILLNESSES
Most are diseases known to paediatricians for many years that have been linked to a causal infecting organism for the first time. Others appear to be new illnesses, or at least recently recognised as occurring in children as well as adults. They are listed in the table. It is possible to consider only some of them further.
Haemolytic uraemic syndrome In addition to the now well known enteropathogenic, enterotoxigenic, and enteroinvasive strains of Escherichia coli, an enterohaemorrhagic variety has been reported, which produces cytotoxins.4 These are known either as Shiga like toxins, being very similar to that produced by Shigella dysenteriae type 1, or as verotoxins, Vero cells being used to detect their cytotoxic nature. A particular serotype of one of them, 0157:H7, seems likely to prove an important aetiological agent for both haemolytic uraemic syndrome (a triad of haemolytic anaemia, thrombocytopenia, and acute renal failure), in which the Shiga like toxin may cause the initial endothelial damage, and haemorrhagic colitis. 17 The recent occurrence of the haemolytic uraemic syndrome and Antibody formation by B lymphocytes needs the collaboration of the CD4 cells. It is the latter that are the primary target of the HIV; as they are lost progressively, so the ability to secrete antibodies is lost. The activity of suppressor T cells is uppermost in the newborn infant, and presumably through most of fetal life.29 Thus there is a suppression of B cell differentiation to B cells and antibody production. The newborn infant also has deficiencies of complement and of certain antibodies-both exaggerated by preterm birth-so that his neutrophil response is less than efficient. Activation is poor, so there is little increase in surface receptors on the cell, and less ability to stick. The cells are unusually rigid, so their ability to adhere to surfaces or move through vascular endothelium to the site of infection is compromised, and hence chemotaxis is slower. Phagocytosis, the ability to engulf micro-organisms, may be normal in otherwise healthy infants, but in stressed or infected infants it is less effective. And the relative lack of enzymes needed for the respir Hepatitis B vaccine is to some extent unique in that if it could be given to all infants born to women carrying the hepatitis B surface antigen, not only is there the prospect of preventing chronic hepatitis, but, perhaps, hepatocellular carcinoma as well.
Some future priorities IMMUNISATION Universal childhood immunisation is one of the four priorities selected by the United Nations Children's Fund (Unicef) in collaboration with the WHO in their drive to improve the health and nutrition of the world's children. The Director General of WHO has been reported as saying that in 1987 just half of the latter were now receiving immunisation against poliomyelitis, diphtheria, pertussis, tetanus, measles, and tuberculosis; the expanded programme was judged to be preventing more than one million deaths from measles, neonatal tetanus, and pertussis, and more than 175 000 cases of poliomyelitis. But the goal of health for all by the year 2000 still faces enormous difficulties in the poverty stricken parts of the world.
The United Kingdom certainly has its own house to put in order too. Given that uptake of immunisation is least in urban areas,46 primary health care teams there need to know that it is primarily their informed attitudes and enthusiasm, backed by efficient organisation, which lead to the desired high uptake.47 It is easy to blame non-compliance or noncompletion of schedules on socioeconomic factors, but this is probably unjustifiable.48 There is no reason for health professionals in this country not to be well informed about the very few contraindications to immunisation existing. Copies of the recently distributed green book49 need to be in every health clinic, and on the desks of general practitioners and paediatricians. The information is clearly set out, should allow those responsible to speak with one voice, and prevent confidence being undermined by the wide coverage given to every pronouncement of the anti-immunisation lobby. The new measles, mumps, and rubella vaccine introduced in October 1988 needs a 95% uptake to eradicate these rarely (at least in this country) lethal, but occasionally very disabling infections. A spirit of healthy competition between districts to achieve such levels for all immunisations in children would not go amiss.
PREVENTION OF CHORIOAMNIONMS ASSOCIATED PRETERM BIRTH
It may seem out of place to discuss this primarily maternal infection here, but I think paediatricians will have to take the lead in urging obstetricians to take chorioamnionitis more seriously. This inflammation of the decidua, fetal membranes, and umbilical cord is mostly clinically silent. It is only diagnosed by pathologists if they decide to look for it and if they receive the placenta in the first place. But it is at its most prevalent at low gestations, and there is increasing suspicion that it is a cause rather than a sequel to premature rupture of the membranes in many cases. There is an urgent need for more paediatricians to make infectious diseases a special interest. The subject will always be of special importance for children. The possibilities for accurate diagnosis and effective treatment, and the opportunities for prevention, have never been greater. 
